Right now BJSM has double blind review — we ask authors to anonymize their papers, reviewers’ names are shrouded in secrecy. BJSM is the only BMJ publication that has this policy.
Is it time to adopt BMJ approach and have open review? Do you believe the evidence that ‘big name’ authors have papers accepted more readily? Do you believe that there are personal and corporate pressures that influence reviewers? Fiona Godlee, editor of BMJ commented on this in 2002.
Let us know on the blog as we reconsider this policy at BJSM.